Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.40 |
| ▸ | CNR1 | P21554 | 14/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19176877 | 0.76 | LMNA (0.42) | CNR2CNR1 | |
| SCHEMBL19176721 | 0.76 | LMNA (0.42) | CNR2CNR1 | |
| SCHEMBL21201306 | 0.75 | ALDH1A1 (0.39) | AR | |
| SCHEMBL4726800 | 0.73 | SMN1; SMN2 (0.42) | CNR2CNR1 | |
| SCHEMBL18681924 | 0.72 | KDM4E (0.44) | CNR2CNR1 | |
| SCHEMBL29426991 | 0.72 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL571943 | 0.72 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL20877706 | 0.71 | CNR2 (0.40) | CNR2CNR1 | |
| SCHEMBL26265942 | 0.71 | CNR2 (0.52) | CNR2CNR1 | |
| SCHEMBL23815855 | 0.70 | KCNH2 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200339530-A1 | UREA DERIVATIVES AS INHIBITORS OF ASK1 | HEPAGENE THERAPEUTICS, INC. (VG) | 2020-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339530-A1 | UREA DERIVATIVES AS INHIBITORS OF ASK1 | ATF1, ERN1, MAP3K1 | CNR2 4755/4885CNR1 4518/4885AR 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.